The 5-HT1A receptor: an overview of recent advances
- PMID: 2052135
- DOI: 10.1007/BF00965820
The 5-HT1A receptor: an overview of recent advances
Abstract
Progress in the field of neuronal receptor research has accelerated during the last few years due to developments in pharmacology and molecular biology. This is particularly true in the case of the serotonin 5-HT1A receptor. In 1983 the very selective, high affinity 5-HT1A agonist 8-OH-DPAT was developed which allowed the pharmacology and distribution of the 5-HT1A receptor in the central nervous system of the rat and man to be extensively characterized. By 1987, the gene encoding this receptor protein was cloned and sequenced, allowing not only elucidation of its structure, but also better insight into the nature of its coupling to transmembrane signal transduction systems. Thus in a short period of time considerable knowledge has accumulated on how serotonin exerts its functions in the central nervous system via the 5-HT1A receptor. In the present review we will briefly discuss some of the latest developments regarding the 5-HT1A receptor.
Similar articles
-
Immunohistochemical mapping of cellular and subcellular distribution of 5-HT1A receptors in rat and human kidneys.Am J Physiol. 1993 Jan;264(1 Pt 2):F9-19. doi: 10.1152/ajprenal.1993.264.1.F9. Am J Physiol. 1993. PMID: 8430834
-
Genomic organization, coding sequence and functional expression of human 5-HT2 and 5-HT1A receptor genes.Eur J Pharmacol. 1992 Oct 1;227(2):153-62. doi: 10.1016/0922-4106(92)90123-d. Eur J Pharmacol. 1992. PMID: 1330647
-
Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.J Neurochem. 1999 Jan;72(1):262-72. doi: 10.1046/j.1471-4159.1999.0720262.x. J Neurochem. 1999. PMID: 9886078
-
The recombinant 5-HT1A receptor: G protein coupling and signalling pathways.Br J Pharmacol. 1999 Aug;127(8):1751-64. doi: 10.1038/sj.bjp.0702723. Br J Pharmacol. 1999. PMID: 10482904 Free PMC article. Review.
-
The serotonin 5-HT1D receptor: a progress review.Neurochem Res. 1990 Jun;15(6):567-82. doi: 10.1007/BF00973745. Neurochem Res. 1990. PMID: 2215849 Review.
Cited by
-
Medicinal Cannabis and Central Nervous System Disorders.Front Pharmacol. 2022 Apr 21;13:881810. doi: 10.3389/fphar.2022.881810. eCollection 2022. Front Pharmacol. 2022. PMID: 35529444 Free PMC article. Review.
-
[3H]-5-carboxamidotryptamine labels 5-HT1D binding sites in bovine substantia nigra.Br J Pharmacol. 1993 Aug;109(4):1206-11. doi: 10.1111/j.1476-5381.1993.tb13750.x. Br J Pharmacol. 1993. PMID: 8401931 Free PMC article.
-
8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding sites in goldfish retina.Neurochem Res. 1994 Mar;19(3):249-55. doi: 10.1007/BF00971572. Neurochem Res. 1994. PMID: 8177365
-
Human serotonin receptor 5-HT(1A) preferentially segregates to the liquid disordered phase in synthetic lipid bilayers.J Am Chem Soc. 2014 Oct 1;136(39):13530-3. doi: 10.1021/ja507221m. Epub 2014 Sep 19. J Am Chem Soc. 2014. PMID: 25211019 Free PMC article.
-
Neurally mediated syncope and serotonin reuptake inhibitors.Clin Auton Res. 1995 Oct;5(5):251-5. doi: 10.1007/BF01818888. Clin Auton Res. 1995. PMID: 8563456 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources